Kai Hong Yuan
Chairman at JIANGSU HENGRUI MEDICINE CO., LTD.
Net worth: 8 M $ as of 2024-03-30
Profile
Kai Hong Yuan is currently the Chairman-Supervisory Board at Jiangsu Hengrui Pharmaceuticals Co., Ltd.
and also holds the position of Director at Tibet Dayuan Investment Co., Ltd.
He completed his undergraduate degree from China Pharmaceutical University in 1987.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2022-10-31 | 1,260,000 ( 0.02% ) | 8 M $ | 2024-03-30 |
Kai Hong Yuan active positions
Companies | Position | Start |
---|---|---|
JIANGSU HENGRUI MEDICINE CO., LTD. | Chairman | 2023-02-01 |
Tibet Dayuan Investment Co., Ltd.
Tibet Dayuan Investment Co., Ltd. Financial ConglomeratesFinance Tibet Dayuan Investment Co., Ltd. engages in the provision of investment services. Its business activities include industrial investment, investment management, and investment advisory services. The company was founded on July 12, 2005 and is headquartered in Lhasa, China. | Director/Board Member | - |
Training of Kai Hong Yuan
China Pharmaceutical University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
JIANGSU HENGRUI MEDICINE CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Tibet Dayuan Investment Co., Ltd.
Tibet Dayuan Investment Co., Ltd. Financial ConglomeratesFinance Tibet Dayuan Investment Co., Ltd. engages in the provision of investment services. Its business activities include industrial investment, investment management, and investment advisory services. The company was founded on July 12, 2005 and is headquartered in Lhasa, China. | Finance |
- Stock Market
- Insiders
- Kai Hong Yuan